Sanofi India share price
You have to be logged in to add this to Watchlist.- ₹6,035.00(0.50%)June 23, 2025 15:25:01 PM IST
- NSE
- BSE
- Vol : 6.57K (NSE + BSE)Last 20 day avg : 6.79 K
Sanofi India is trading 0.50% upper at Rs 6,035.00 as compared to its last closing price. Sanofi India has been trading in the price range of 6,035.00 & 5,952.95. Sanofi India has given -1.56% in this year & -1.62% in the last 5 days. Sanofi India has TTM P/E ratio 36.50 as compared to the sector P/E of 22.54.There are 2 analysts who have initiated coverage on Sanofi India. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 119.50 Crores in its last quarter.Listed peers of Sanofi India include Natco Pharma (-0.84%), Caplin Point Laboratories (-1.28%), Sanofi India (0.50%).The Mutual Fund holding in Sanofi India was at 11.26% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Sanofi India was at 5.58% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Jun 24, 2025, 01:08 AM UTC
- Dividend YieldHigher than industry1.94Annual dividends as a percentage of the stock price.
- P/BHigher than historical values16.13The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values35.03Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.60Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in June quarter by 4.91% from Rs 535.90 crore to Rs 510.80 crore, year-on-year
The company's profit declined by 12.52% year-on-year during the June quarter, dropping from Rs 136.60 crore to Rs 119.50 crore- The debt to equity of the company is higher than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 6,380.98
- R2
- 6,553.02
- R3
- 6,767.03
- S1
- 5,994.93
- S2
- 5,780.92
- S3
- 5,608.88
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Natco Pharma | Bearish | 867.95 | -0.84 | 15,545.84 | 8.31 | 2.06 | 0.69 | 0.06 |
| Caplin Point Laboratories | Neutral | 2,022.00 | -1.28 | 15,468.50 | 29.12 | 5.45 | 0.27 | 0.10 |
| Sanofi India | Moderately Bearish | 6,035.00 | 0.50 | 13,898.61 | 40.60 | 16.08 | 1.95 | 1.63 |
| Alivus Life Sciences | Bearish | 993.00 | -0.71 | 12,112.28 | 25.26 | 4.34 | 2.25 | 1.81 |
| Granules India | Bearish | 497.45 | 2.18 | 12,128.86 | 24.72 | 3.18 | 0.31 | 12.67 |
- Promoter(s) holds a high stake in the company at 60.40%
- FIIs are invested in this company
- FIIs holding has decreased by 0.06 percentage points from previous quarter
- Mutual Funds holding has increased by 0.21 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-14 | Quarterly Results |
| 2025-02-27 | Audited Results & Final Dividend |
| 2024-11-07 | Quarterly Results |
| 2024-07-26 | Quarterly Results |
| 2024-05-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE058A01010
- BSE Code500674
- NSE CodeSANOFI
Sanofi India is trading at 6035.00 as on Mon Jun 23 2025 09:55:01. This is 0.50% upper as compared to its previous closing price of 6005.10.
The market capitalization of Sanofi India is 13898.61 Cr as on Mon Jun 23 2025 09:55:01.
The average broker rating on Sanofi India is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Sanofi India is 7593.60 whereas the 52 wk low is 4145.90
Sanofi India can be analyzed on the following key metrics -
- TTM P/E: 36.50
- Sector P/E: 22.54
- Dividend Yield: 1.94%
- D/E ratio: -
Sanofi India reported a net profit of 413.30 Cr in 2024.
The Mutual Fund Shareholding was 11.26% at the end of 31 Mar 2025.